A Novel Allosteric Modulator of the Cannabinoid CB1 Receptor Ameliorates Hyperdopaminergia Endophenotypes in Rodent Models

Catharine A Mielnik* (Corresponding Author), Kim S Sugamori, David B Finlay, Hayley H A Thorpe, Matthieu Schapira, Nirunthan Sivananthan, Chun Kit Li, Vincent M lam, Sean Harrington, Mostafa H Abdelrahman, Laurent A Trembleau, W. McIntyre Burnham, Jibran Y Khokhar, Ali Salahpour, Amy J Ramsey, Michelle Glass, Iain Greig, Ruth A. Ross* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticle

Original languageEnglish
JournalNeuropsychopharmacology
Publication statusAccepted/In press - 10 Aug 2020

Keywords

  • cannabinoid
  • Allosteric modulator
  • psychosis
  • hyperdopaminergia

Cite this

Mielnik, C. A., Sugamori, K. S., Finlay, D. B., Thorpe, H. H. A., Schapira, M., Sivananthan, N., Li, C. K., lam, V. M., Harrington, S., Abdelrahman, M. H., Trembleau, L. A., Burnham, W. M., Khokhar, J. Y., Salahpour, A., Ramsey, A. J., Glass, M., Greig, I., & Ross, R. A. (Accepted/In press). A Novel Allosteric Modulator of the Cannabinoid CB1 Receptor Ameliorates Hyperdopaminergia Endophenotypes in Rodent Models. Neuropsychopharmacology.